Megapro Biomedical Co., Ltd.TPEX: 6827

MegaPro Submits Application To FDA To Conduct Phase III Trial On MPB-1523

· Issued by Megapro Biomedical Co., Ltd.

MegaPro Biomedical Co Ltd TPEX:6827:

  • SAYS CO SUBMITS APPLICATION TO U.S. FDA TO CONDUCT PHASE III CLINICAL TRIAL ON NEW DRUG MPB-1523